Clinical trial
Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus…
NCT00098293 · ViiV Healthcare, Industry · Completed
Key facts
| NCT number | NCT00098293 |
|---|---|
| Title | Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine |
| Official title | A Multicenter, Randomized, Double-Blind, Comparative Trial Of A Novel CCR5 Antagonist, UK-427,857, In Combination With Zidovudine/Lamivudine Versus Efavirenz In Combination With Zidovudine/Lamivudine For The Treatment Of Antiretroviral-Naive HIV-1 Infected Subjects |
| Acronym | MERIT |
| Lead sponsor | ViiV Healthcare, Industry |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV-1 |
| Intervention type | Drug |
| Interventions | Maraviroc + Zidovudine/Lamivudine, Efavirenz + Zidovudine/Lamivudine, Maraviroc (UK-427, 857) + Zidovudine/Lamivudine |
| Enrollment | 916 |
| Start date | Nov 1, 2004 |
| Primary completion | Apr 1, 2007 |
| Completion | Dec 1, 2012 |
| First posted | Dec 7, 2004 |
| Last update posted | Oct 9, 2013 |
| Countries | Argentina, Australia, Belgium, Brazil, Canada, Italy, Mexico, Netherlands, Poland, Puerto Rico, South Africa, Switzerland and 2 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: